Oruka Therapeutics, Inc. SEC filings ORKA
Oruka Therapeutics, Inc. has 1,001 filings in SEC EDGAR's recent list, going back to Jun 26, 2009. Its latest annual report, Form ARS, was filed on Apr 17, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 10, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 26, 2026 (regulation fd disclosure, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 10, 2026 | Jun 30, 2026 |
| 10-Q | Quarterly report | May 13, 2026 | Mar 31, 2026 |
| 10-Q | Quarterly report | Nov 12, 2025 | Sep 30, 2025 |
| 10-Q | Quarterly report | Aug 11, 2025 | Jun 30, 2025 |
| 10-Q | Quarterly report | May 14, 2025 | Mar 31, 2025 |
| 10-Q | Quarterly report | Nov 13, 2024 | Sep 30, 2024 |
| 10-Q | Quarterly report | Aug 1, 2024 | Jun 30, 2024 |
| 10-Q | Quarterly report | Apr 25, 2024 | Mar 31, 2024 |
| 10-Q | Quarterly report | Oct 18, 2023 | Sep 30, 2023 |
| 10-Q | Quarterly report | Jul 21, 2023 | Jun 30, 2023 |
| 10-Q | Quarterly report | Apr 24, 2023 | Mar 31, 2023 |
| 10-Q | Quarterly report | Oct 28, 2022 | Sep 30, 2022 |
| 10-Q | Quarterly report | Aug 2, 2022 | Jun 30, 2022 |
| 10-Q | Quarterly report | May 2, 2022 | Mar 31, 2022 |
| 10-Q | Quarterly report | Nov 2, 2021 | Sep 30, 2021 |
| 10-Q | Quarterly report | Aug 4, 2021 | Jun 30, 2021 |
| 10-Q | Quarterly report | May 11, 2021 | Mar 31, 2021 |
| 10-Q | Quarterly report | Nov 2, 2020 | Sep 30, 2020 |
| 10-Q | Quarterly report | Aug 5, 2020 | Jun 30, 2020 |
| 10-Q | Quarterly report | May 6, 2020 | Mar 31, 2020 |
| 10-Q | Quarterly report | Nov 6, 2019 | Sep 30, 2019 |
| 10-Q | Quarterly report | Aug 1, 2019 | Jun 30, 2019 |
| 10-Q | Quarterly report | May 8, 2019 | Mar 31, 2019 |
| 10-Q | Quarterly report | Nov 14, 2018 | Sep 30, 2018 |
| 10-Q | Quarterly report | Aug 9, 2018 | Jun 30, 2018 |
| 10-Q | Quarterly report | May 8, 2018 | Mar 31, 2018 |
| 10-Q | Quarterly report | Nov 9, 2017 | Sep 30, 2017 |
| 10-Q | Quarterly report | Aug 3, 2017 | Jun 30, 2017 |
| 10-Q | Quarterly report | May 15, 2017 | Mar 31, 2017 |
| 10-Q | Quarterly report | Nov 14, 2016 | Sep 30, 2016 |
| 10-Q | Quarterly report | Aug 9, 2016 | Jun 30, 2016 |
| 10-Q | Quarterly report | May 11, 2016 | Mar 31, 2016 |
| 10-Q | Quarterly report | Nov 12, 2015 | Sep 30, 2015 |
| 10-Q | Quarterly report | Aug 11, 2015 | Jun 30, 2015 |
| 10-Q | Quarterly report | May 12, 2015 | Mar 31, 2015 |
| 10-Q | Quarterly report | Nov 12, 2014 | Sep 30, 2014 |
| 10-Q | Quarterly report | Aug 13, 2014 | Jun 30, 2014 |
| 10-Q | Quarterly report | May 13, 2014 | Mar 31, 2014 |
| 10-Q | Quarterly report | Nov 13, 2013 | Sep 30, 2013 |
| 10-Q | Quarterly report | Aug 13, 2013 | Jun 30, 2013 |
| 10-Q | Quarterly report | May 13, 2013 | Mar 31, 2013 |
| 10-Q | Quarterly report | Nov 13, 2012 | Sep 30, 2012 |
| 10-Q | Quarterly report | Aug 13, 2012 | Jun 30, 2012 |
| 10-Q | Quarterly report | May 14, 2012 | Mar 31, 2012 |
| 10-Q | Quarterly report | Nov 14, 2011 | Sep 30, 2011 |
| 10-Q | Quarterly report | Aug 15, 2011 | Jun 30, 2011 |
| 10-Q | Quarterly report | May 16, 2011 | Mar 31, 2011 |
| 10-Q | Quarterly report | Nov 15, 2010 | Sep 30, 2010 |
| 10-Q | Quarterly report | Aug 10, 2010 | Jun 30, 2010 |
| 10-Q | Quarterly report | May 10, 2010 | Mar 31, 2010 |
| 10-Q | Quarterly report | Nov 16, 2009 | Sep 30, 2009 |
| 10-Q/A | Amended quarterly report | Nov 6, 2009 | Mar 31, 2009 |
| 10-Q/A | Amended quarterly report | Aug 21, 2009 | Jun 30, 2009 |
| 10-Q | Quarterly report | Aug 10, 2009 | Jun 30, 2009 |
Showing 54 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ORKA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Menlo Park, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 907654
- Former names
- ARCA biopharma, Inc. (until Aug 30, 2024); NUVELO INC (until Jan 27, 2009); HYSEQ INC (until Jan 28, 2003)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.